Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials

被引：0
|
作者：
Kitley, J. [1 ]
Leite, M. I. [1 ]
Elsone, L. [2 ]
Jacob, A. [2 ]
Palace, J. [1 ]
机构：
[1] John Radcliffe Hosp, Oxford OX3 9DU, England
[2] Walton Ctr Neurol & Neurosurg, Liverpool, Merseyside, England
来源：
MULTIPLE SCLEROSIS JOURNAL | 2013年 / 19卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：331 / 332
页数：2
相关论文
共 50 条
  • [1] Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials
    Kitley, Joanna
    Leite, M. Isabel
    Elsone, Liene
    Jacob, Anu
    Palace, Jackie
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2014, 85 (05): : 589 - U118
  • [2] Time to first relapse as an endpoint in multiple sclerosis clinical trials
    Sormani, M. P.
    Signori, A.
    Siri, P.
    De Stefano, N.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (04) : 466 - 474
  • [3] Hypothalamic Relapse in Neuromyelitis Optica
    McKenna, Mary Clare
    Bradley, David
    [J]. NEUROLOGY, 2020, 94 (15)
  • [4] Time to Next Treatment as a Meaningful Endpoint for Trials of Primary Cutaneous Lymphoma
    Campbell, Belinda A.
    Scarisbrick, Julia J.
    Kim, Youn H.
    Wilcox, Ryan A.
    McCormack, Christopher
    Prince, H. Miles
    [J]. CANCERS, 2020, 12 (08) : 1 - 11
  • [5] Challenges and opportunities in designing clinical trials for neuromyelitis optica
    Weinshenker, Brian G.
    Barron, Gerard
    Behne, Jacinta M.
    Bennett, Jeffery L.
    Chin, Peter S.
    Cree, Bruce A. C.
    de Seze, Jerome
    Flor, Armando
    Fujihara, Kazuo
    Greenberg, Benjamin
    Higashi, Sayumi
    Holt, William
    Khan, Omar
    Knappertz, Volker
    Levy, Michael
    Melia, Angela T.
    Palace, Jacqueline
    Smith, Terry J.
    Sormani, Maria Pia
    Van Herle, Katja
    VanMeter, Susan
    Villoslada, Pablo
    Walton, Marc K.
    Wasiewski, Warren
    Wingerchuk, Dean M.
    Yeaman, Michael R.
    [J]. NEUROLOGY, 2015, 84 (17) : 1805 - 1815
  • [6] Heterogenous relapse and efficacy endpoint definitions for neuromyelitis optica spectrum disorder studies: A systematic review
    Rocha, Rebeka Bustamante
    Bomtempo, Fernanda Ferreira
    Tadinac, Ana Claudia Benevides
    Allioni, Gabriela Abrahao
    Silva, Guilherme Diogo
    Telles, Joao Paulo Mota
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 91
  • [7] Statistical properties of time to first relapse as an endpoint in multiple sclerosis clinical trials
    Signori, A.
    Siri, P.
    Sormani, M. P.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 29 - 30
  • [8] NatalizumabBrain relapse of neuromyelitis optica: case report
    [J]. Reactions Weekly, 2015, 1537 (1) : 191 - 191
  • [9] Relapse of neuromyelitis optica associated with oral progestin
    Li, Li-Min
    Zhang, Chao
    Zhang, Lin-Jie
    Guo, Hui-Yue
    Yang, Chun-Sheng
    Zhang, Rui
    Li, Yu-Jing
    Shi, Fu-Dong
    Yang, Li
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (07): : 788 - +
  • [10] Isolated Occipital Neuralgia as a Relapse of Neuromyelitis Optica
    Martin, Andrew
    Garcia, Maria C.
    [J]. NEUROLOGY-CLINICAL PRACTICE, 2021, 11 (06) : E977 - E979
12345